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Malignancies of the sinonasal cavity are 
uncommon, accounting for 3 - 5% of all 
malignancies of the head and neck.[1,2] The 
predominant histological subtype of sinonasal 
tumours is sinonasal squamous cell carcinoma 
(SNSCC), accounting for up to 50 - 80% 
of all sinonasal malignancies. These most 
commonly occur in the maxillary sinus.[2] 
The remaining 10 - 20% are intestinal-type 
adenocarcinoma, which mostly occur in the 
ethmoid sinus.[2] There have been fewer than 
500 reported cases of primary squamous cell 
carcinoma of the ethmoid sinus in the English 
literature.[3-15] Sinonasal tumours typically 
present between the 5th and 6th decades of 
life.[2] Environmental exposures to wood and 
leather dust, as well as glues, formaldehyde, 
nickel and chrome, are strongly associated with 
the development of some sinonasal tumours.[2]
Case report
A 31-year-old black African man presented 
to our department with a 5-month history 
of swelling of the left side of the forehead, 
associated with a dull frontal headache and 
with progressive painless blindness of the 
left eye. The patient also reported a decrease 
in his sense of smell, along with loss of 
taste. There had also been an intermittent 
report of a bloodstained nasal discharge. 
The patient was an occasional smoker, with 
no occupational exposure to wood dust 
or industrial and textile compounds. He 
was HIV-negative. The physical examination 
revealed a 6 × 5 cm diffuse, ill-defined, 
firm, mildly tender mass over the lower 
part of the left forehead. It appeared to be 
the head of a mushroom-type growth, with 
the stem arising through the nasion. The 
mass dominated over the left forehead with 
encroachment to the left medial epicanthal 
area, without causing epiphorea. There was 
intraorbital mass effect with proptosis and 
leftward and downward displacement of 
the globe, without ophthalmoplegia. His 
decreased visual acuity implied optic canal/
optic nerve involvement. There was no ptosis 
or chemosis. Anterior rhinoscopy revealed 
no intranasal sinus disease. Endoscopic 
middle meatus examination showed an ill-
defined ethmoid tumour mass not extending 
inferiorly. The drainage ostia of the maxillary 
sinus and anterior ethmoids were clear of 
disease. Endoscopic examination of the 
cribriform plate area was difficult owing 
to the distortion of the middle turbinate 
superiorly. Apart from cranial nerve I (loss 
of smell) and cranial nerve II (decreased 
visual acuity), all other cranial nerves were 
functionally intact.
A computed tomography (CT) scan 
showed a soft-tissue mass with contrast 
enhancement originating in the ethmoid 
sinus and extending superolaterally to the 
left side and infiltrating through the floor 
and posterior table of frontal sinus. There 
was also erosion through the cribriform 
plate. Destruction of the frontal sinus and 
frontal bone with intracranial extension into 
the frontal lobe was evident. Proptosis of 
the left orbit with destruction of the left 
bony orbital roof and lamina papyracea 
medially was noted. Magnetic resonance 
imaging (MRI) confirmed the mass as seen 
on the CT scan, with the tumour abutting 
and encasing the left extraconal optic nerve 
and with direct extension to the left frontal 
lobe (Fig. 1). A formal external open tissue 
biopsy via a Lynch incision was undertaken, 
under general anaesthesia.
The histopathological report was that of 
an invasive, moderately to poorly differenti-
ated squamous cell carcinoma. Immuno-
histochemical staining, carried out to detect 
human papillomavirus and/or Epstein-Barr 
virus infection, was negative. Surgical resec-
tion was deemed contraindicated owing to 
the erosion of the tumour directly through 
the cribriform plate to the frontal lobe, 
transgressing the cerebrospinal fluid space. 
Further treatment therefore involved 
radiation and cycles of chemotherapy.
Discussion
Primary ethmoid SNSCCs make up 5 - 25% 
of all sinus malignan cies.[10] The literature 
is deficient on the precise incidence, as 
ethmoid tumours are often grouped with 
more common maxillary and nasal tumours. 
Squamous cell carcinomas are often grouped 
with other tumours, which may occur 
primarily within the ethmoid sinuses.[10] 
While the average age of primary ethmoid 
SNSCC onset is known, only a few reports 
detailing a young age of onset are currently 
available in the published literature. The 
tumorigenesis of paranasal sinus tumours is 
unknown. Theories abound regarding certain 
chemical or viral agents that cause persistent 
or chronic inflammatory changes. [2] Chronic 
inflammation in turn results in aberrant 
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Fig. 1. T1 coronal MRI scan showing the epicentre 
of the tumour mass (arrow) in the ethmoid sinus 
with intracranial extension and erosion of frontal 
bone.
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activation of tumour suppressor genes that support tumori genesis. [2] 
The above fails to explain the development of SNSCC in young 
patients or patients who have not been exposed to any known 
carcinogens. Early-onset tumorigenesis in young patients could be 
attributed to existing genetic precursor lesions and the accumulation 
of genetic alterations.[2] The optimal care for patients with localised 
sinonasal carcinoma is complete surgical resection and postoperative 
radiotherapy.[2] Ansa et al.[1] showed the combination of surgery and 
radiation to be superior to radiation alone.
Conclusion
A complex interplay between genetic factors and yet-to-be-identified 
environmental triggers is likely to have contributed to the development 
of primary ethmoid SNSCC in an unusually young patient with a 
limited risk profile. Unveiling the molecular pathophysiology of 
SNSCC is likely to uncover potential molecular diagnostic markers 
and aid the identification of specific treatment modalities.
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